ABSTRACT Sclerosing angiomatoid nodular transformation (SANT) is an exceedingly rare, benign and proliferative vascular lesion that arises from the splenic red pulp. It is often an incidental fi nding on imaging. The diagnosis of SANT is confi rmed via histopathological examination of the resected spleen. Herein, we present a case of SANT and describe its typical imaging characteristics. An asymptomatic 39-year-old man was found to have a 3.1 cm × 2.7 cm × 2.3 cm hypoechoic splenic lesion during abdominal ultrasonography, which was performed to investigate his elevated gammaglutamyl transpeptidase and alanine transaminase levels. Contrast-enhanced computed tomography suggested a vascular splenic lesion, while magnetic resonance imaging demonstrated features consistent with SANT. In view of the increasing size of the lesion on follow-up imaging, the patient elected for splenectomy. Histopathological examination confi rmed SANT, and the lesion was completely resected by laparoscopic splenectomy.
INTRODUCTION
Sclerosing angiomatoid nodular transformation (SANT) is an exceedingly rare tumour of the spleen. The term was fi rst introduced by Martel et al in 2004 to describe a group of morphologically distinct vascular lesions of the spleen.
(1) These lesions, which are benign, non-neoplastic and vascular in nature, can be completely resected by splenectomy. Approximately 50 cases of SANT have been reviewed in the literature that is available in English. (1) (2) (3) (4) (5) (6) To the best of our knowledge, this is the fi rst case of SANT in which the lesion was observed to increase in size over time.
CASE REPORT
Our patient, a 39-year-old man, was found to have raised gamma-glutamyl transpeptidase (247 μ/L) and alanine transaminase (45 μ/L) levels during a private medical health screening session in August 2011. Initial ultrasonography (US) performed was unremarkable aside from a 3.1 cm × 2.7 cm × 2.3 cm well-defi ned hypoechoic lesion in the spleen (Fig. 1a) . Although it was deemed to be an indeterminate lesion, the possibility that it was a cyst was considered. No vascularity was demonstrated on Doppler imaging (Fig. 1b) .
On follow-up US in December 2012, the hypoechoic splenic lesion showed an interval increase in size, measuring 4.0 cm × 3.9 cm × 3.0 cm. Contrast-enhanced computed tomography (CT) was performed, and a well-defi ned, ovoid hypoattenuating lesion measuring 4.6 cm × 3.4 cm (in axial dimensions) was seen in the spleen during the portal venous phase, with 'fi lling in' of contrast and increasing homogeneity to the splenic parenchyma in the delayed phase (Fig. 2) . While splenic haemangioma was the primary differential diagnosis, a further evaluation with magnetic resonance (MR) imaging was performed.
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On MR imaging, the lesion was noted to be entirely within the spleen. On T1-weighted sequences, the lesion appeared isointense to the splenic parenchyma (Fig. 3a) . No variation in the signal was seen on the T1-weighted inphase and T1-weighted out-of-phase sequences. It was mildly hypointense on T2-weighted sequences, with a central stellate hypointense focus (Fig. 3b ) that is typically seen in SANT. Early arterial enhancement with subsequent centripetal fi lling was noted following the administration of an intravenous contrast medium (MultiHance, Bracco Imaging, Courcouronnes, France). A central low-signal, nonenhancing focus (corresponding to the aforementioned stellate focus) was attributed to fi brosis (Fig. 4) . Although follow-up CT (performed in June 2013) revealed enhancement characteristics that were similar to those observed in the initial CT, the splenic lesion demonstrated a mild interval size increase, measuring 4.9 cm × 4.0 cm (Fig. 5 ).
The patient elected to undergo laparoscopic splenectomy. Surgery was performed under general anaesthesia with the patient in the supine position. Infraumbilical, left hypochondrium midclavicular line and left hypochondrium anterior axillary line incisions were made for ports. The entire spleen was delivered via a periumbilical midline incision. The removed spleen measured 11.0 cm × 9.0 cm × 7.0 cm and weighed 277.2 g. Macroscopically, a well-circumscribed tumour measuring 5.0 cm × 4.5 cm × 4.5 cm was identifi ed; it had a central area of fi brosis that was surrounded by peripheral dark reddish areas. The closest distance to the splenic capsule measured less than 0.1 cm. No other splenic lesion was identifi ed.
On microscopy, the tumour was composed of hypocellular fi brosclerotic areas, with scattered bland spindled myofi broblastic and fi broblastic cells, and few associated lymphocytes and plasma cells. No necrosis or mitosis was evident and obliterative phlebitis, granulomas or follicular dendritic cell proliferation was not observed. Irregular to nodular vascular areas resembling splenic red pulp were interspersed between the areas of sclerosis. These vascular areas were made of residual sinusoids and a complex network of cord capillaries, which were associated with many extravasated red blood cells and surrounded by vaguely concentric layers of hyalinised collagen bundles at the periphery (Figs. 6 & 7) . These features were consistent with SANT of the spleen.
DISCUSSION
SANT is an exceedingly rare, benign and vascular lesion of the spleen. Since it was fi rst described by Martel et al in 2004, (1) approximately 50 cases have been mentioned in the English literature.
(1-6) While its pathogenesis has yet to be fully understood, Martel et al suggested that the nodules in SANT are derived from splenic red pulp and that they arise due to nodular transformation.
(1) They postulate that the nodular transformation occurs in response to an exaggerated non-neoplastic stromal proliferation, resulting in outfl ow disruption of the small vascular tracts and subsequent nodular or hyperplastic changes of the proximal vascular tract.
(1) As SANT comprises splenic red pulp, it may also be considered a peculiar form of splenic hamartoma.
The mean age at presentation for SANT is 53.7 (range 22-74) years. (3) There is female predominance, with a female-tomale ratio of 2:1.
(1) The resected spleen is usually normal in size or mildly enlarged, with a mean weight of 386 (range 68-1,425) g. (3) The lesion usually ranges from 3 cm to 17 cm in diameter.
(1,7) As most patients are asymptomatic, the splenic mass is often an incidental fi nding during laparotomy or on imaging studies performed for unrelated conditions. Approximately 16% of patients with SANT complain of discomfort or abdominal pain. (3) A small proportion of patients present with splenomegaly, which has rarely been associated with leucocytosis, polyclonal gammopathy and increased erythrocyte sedimentation rate. (1) Splenectomy is considered curative, with no case of recurrence reported following surgical resection of SANT. (1) (2) (3) (4) (5) (6) SANT has a distinctive macroscopic appearance. It is a wellcircumscribed, non-encapsulated mass composed of numerous nodules derived from splenic red pulp, with alternating bands of dense fi brous tissue that coalesce to form a central, stellate fi brous scar. (1, 8) The nodules usually vary in size, are round-or ovalshaped, and may be surrounded by dense concentric collagen fi bres or a fi brin rim (resulting in a granuloma-like or necrotising vasculitic appearance). (3) Microscopically, SANT is identifi ed by multiple nodular aggregates of plump endothelial cells and prominent slit-like vascular spaces that are lined by pericytes. (1) (2) (3) 7) The nodules are associated with extravasated erythrocytes. The intervening collagenous stroma between the nodules contains a variable number of reactive myofibroblasts, haemosiderin-laden macrophages, lymphocytes and plasma cells. The endothelial cells exhibit minimal cytologic atypia, and mitotic activity is rarely observed.
(1-3,7) Preoperative diagnosis of SANT is usually diffi cult, and a confi rmatory diagnosis is often achievable only with postoperative histopathologic examination. (9) In one reported case of SANT, a percutaneous core biopsy was used for diagnosis, with the caveat that an increased frequency of complications (e.g. haemorrhage and splenic rupture) was noted following percutaneous biopsies of vascular splenic lesions. (8, 10) An immunostained SANT specimen typically shows the presence of sinusoidal, capillary-like and vein-like elements within the nodules.
( -endothelium). (3) Focal expression of CD68 within the nodules may be seen, indicating an active phagocytic process in response to increased splenic activity (7) ; this further reinforces the non-neoplastic nature of SANT.
Abdominal US of SANT usually reveals a hypoechoic splenic lesion, although the lesion appeared isoechoic in one out of fi ve patients in a case report. (8) A 'spoke-wheel' pattern may be observed on contrast-enhanced US. (11) On unenhanced CT, the lesion usually appears heterogeneously hypoattenuating with circumscribed margins. Peripheral rim-style enhancement of the external borders of the lesion is observed following intravenous administration of a contrast medium. On delayed CT, the lesion shows more homogeneous enhancement. (12) On MR imaging, an increase in signal on the out-of-phase T1 sequence may suggest the presence of iron, which in SANT, is likely due to the haemorrhagic nature of the lesion. (13) T2-weighted MR imaging typically shows peripheral hypointensity with a central hypointense focus. Following intravenous administration of a contrast medium, a persistent low-central signal on T1-and T2-weighted images, with progressive enhancement from the periphery to the centre of the lesion, is usually seen; this is concordant with the gross pathologic appearance of a central fi brous stroma and peripheral nodules of angiomatoid tissue. (11) In evaluating vascular lesions, differentials for SANT would include splenic haemangioma, splenic haemangioendothelioma, infl ammatory myofi broblastic tumour and splenic hamartoma. However, the presence of a characteristic hypointense central stellate scar alludes to a diagnosis of SANT. While the 'spokewheel' pattern has been characteristically described, (14) it is not seen in all patients with SANT. (8) Increased tracer uptake by SANT on fl uorodeoxyglucose-positron emission tomography suggests hypermetabolic activity and fl uorodeoxyglucose avidity, both of which may be due to the presence of haemosiderin-laden macrophages, myofi broblasts and plasma cells. In SANT, no uptake of Technetium-99m (99 mTc)-sulphur colloid is seen on 99 mTc-sulphur colloid single-photon emission CT due to the absence of reticuloendothelial cells. (13) In conclusion, we described a rare case of SANT of the spleen and its imaging fi ndings on US, CT and MR imaging. The patient in this case study was asymptomatic and elected for laparoscopic splenectomy. To the best of our knowledge, this is the fi rst case of SANT in which the size of the lesion increased over time.
